Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate

Details for Australian Patent Application No. 2002318302 (hide)

International Classifications

Event Publications

9 January 2003 Complete Application Filed

Priority application(s): 09/903,803 12.07.01 US

22 May 2003 Application Open to Public Inspection

Published as AU-B-2002318302

15 March 2007 Application Accepted

Published as AU-B-2002318302

26 July 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 27 Jun 2007. Address for service in Australia - Watermark Patent & Trademark Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122

9 August 2007 Standard Patent Sealed

6 December 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 27 Jun 2007 2003

7 August 2008 Section 223 Application Received

Celgene Corporation An application to extend the time from 15 Jun 2007 to 15 Mar 2008 in which to file search results has been filed . Address for service in Australia - Watermark Patent & Trademark Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122

25 September 2008 Section 223 Application Allowed

Celgene Corporation The time in which to file search results has been extended to 15 Mar 2008. Address for service in Australia - Watermark Patent & Trademark Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.